WallStSmart
GSK

GlaxoSmithKline PLC ADR

NYSE: GSK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$52.31
+1.77% today

Updated 2026-04-30

Market cap
$104.41B
P/E ratio
13.62
P/S ratio
3.19x
EPS (TTM)
$3.84
Dividend yield
3.44%
52W range
$34 – $61
Volume
4.7M

GlaxoSmithKline PLC ADR (GSK) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$3.96B$5.79B$7.31B$7.84B$6.80B$6.25B$4.38B$7.22B$5.18B$2.57B$6.50B$6.92B$8.42B$8.02B$8.44B$7.95B$7.40B$7.89B$6.55B$7.14B
Capital expenditures$1.59B$2.14B$2.07B$1.87B$1.64B$1.33B$1.52B$1.70B$1.75B$1.90B$2.35B$2.20B$1.80B$2.16B$2.24B$2.93B$2.26B$1.63B$2.98B$1.32B
Depreciation
Stock-based comp$179.00M$179.00M$198.00M$220.00M$319.00M$332.00M$368.00M$319.00M$333.00M$360.00M$365.00M$381.00M$367.00M$346.00M$307.00M$344.00M$374.00M
Free cash flow$2.37B$3.65B$5.24B$5.97B$5.16B$4.92B$2.85B$5.52B$3.42B$668.00M$4.14B$4.72B$6.63B$5.86B$6.20B$5.02B$5.14B$6.26B$3.57B$5.82B
Investing cash flow
Financing cash flow
Dividends paid$2.60B$2.79B$3.01B$3.09B$3.21B$3.41B$3.81B$3.68B$3.84B$3.87B$4.85B$3.91B$3.93B$3.95B$3.98B$4.00B$3.47B$2.79B$2.44B$2.51B
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00